Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| SAVA | Cassava Sciences, Inc. | -5.17% | 45.85 | 0.0% | $310.78m | |
| HZNP | Horizon Therapeutics Plc | -3.75% | 99.84 | 5.4% | $183.34m | |
| VRX | Valeant Pharmaceuticals International, Inc. | 1.11% | 23.72 | 14.1% | $139.57m | |
| CTLT | Catalent, Inc. | -4.16% | 122.34 | 2.0% | $135.52m | |
| ICLR | ICON plc | -0.09% | 272.81 | 2.8% | $113.95m | |
| UTHR | United Therapeutics Corp. | -1.74% | 185.99 | 13.9% | $77.42m | |
| JAZZ | Jazz Pharmaceuticals Plc | -1.99% | 120.26 | 2.1% | $74.09m | |
| BHC | Bausch Health Cos., Inc. | 1.11% | 23.72 | 0.0% | $61.74m | |
| PRGO | Perrigo Co. Plc | -0.17% | 35.77 | 6.9% | $60.39m | |
| ARGX | argenx SE | -3.80% | 283.70 | 0.0% | $54.64m | |
| CPIX | Cumberland Pharmaceuticals, Inc. | 8.77% | 4.59 | 0.6% | $52.10m | |
| ENDP | Endo International Plc | -5.49% | 4.99 | 8.5% | $44.06m | |
| IRWD | Ironwood Pharmaceuticals, Inc. | -1.17% | 10.98 | 9.5% | $26.09m | |
| PCRX | Pacira Biosciences, Inc. | -2.27% | 52.53 | 9.8% | $24.74m | |
| AXSM | Axsome Therapeutics, Inc. | -3.33% | 32.24 | 1.8% | $22.87m |
Company Profile
Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on June 22, 2005 and is headquartered in Durham, NC.